Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study

Authors: Toni K. Choueiri, David F. McDermott, Jaime R. Merchan, Todd M. Bauer, Robert A. Figlin, Elisabeth I. Heath, M. Dror Michaelson, Edward Arrowsmith, Anishka D'souza, Zhao Song, Ananya Roy, Rodolfo F. Perini, Donna Vickery, Scott S. Tykodi - The Lancet 2023 cited by 98